NO176275C - Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater - Google Patents
Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivaterInfo
- Publication number
- NO176275C NO176275C NO894088A NO894088A NO176275C NO 176275 C NO176275 C NO 176275C NO 894088 A NO894088 A NO 894088A NO 894088 A NO894088 A NO 894088A NO 176275 C NO176275 C NO 176275C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutically active
- analogous process
- pyridazinone derivatives
- active pyridazinone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/36—Benzo-cinnolines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3161888 | 1988-02-13 | ||
| JP7591088 | 1988-03-31 | ||
| PCT/JP1989/000127 WO1989007594A1 (en) | 1988-02-13 | 1989-02-09 | Pyridazinone derivatives |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO894088L NO894088L (no) | 1989-10-12 |
| NO894088D0 NO894088D0 (no) | 1989-10-12 |
| NO176275B NO176275B (no) | 1994-11-28 |
| NO176275C true NO176275C (no) | 1995-03-08 |
Family
ID=26370117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO894088A NO176275C (no) | 1988-02-13 | 1989-10-12 | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5110925A (da) |
| EP (1) | EP0357788B1 (da) |
| JP (1) | JP2717687B2 (da) |
| KR (1) | KR910005233B1 (da) |
| CA (1) | CA1320957C (da) |
| DE (1) | DE68910447T2 (da) |
| DK (1) | DK170096B1 (da) |
| ES (1) | ES2012646A6 (da) |
| FI (1) | FI95570C (da) |
| NO (1) | NO176275C (da) |
| WO (1) | WO1989007594A1 (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8903130D0 (en) * | 1989-02-11 | 1989-03-30 | Orion Yhtymae Oy | Substituted pyridazinones |
| JP2806192B2 (ja) * | 1992-11-02 | 1998-09-30 | 日本曹達株式会社 | 血小板凝集抑制剤 |
| US5678114A (en) * | 1994-06-14 | 1997-10-14 | Noritsu Koki Co., Ltd. | Automatic photographic developing apparatus for photosensitive materials |
| EP0791584A4 (en) * | 1994-11-11 | 1997-11-19 | Nippon Soda Co | OPTICALLY ACTIVE CONNECTIONS |
| JP2001500865A (ja) * | 1996-09-13 | 2001-01-23 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ | 避妊の非ホルモン法 |
| WO2000021935A1 (fr) * | 1998-10-09 | 2000-04-20 | Nihon Nohyaku Co., Ltd. | Derives de la pyridazinone |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| EP1956906A4 (en) | 2005-11-09 | 2009-12-30 | Combinatorx Inc | METHODS, COMPOSITIONS AND KITS FOR THE TREATMENT OF PATHOLOGIES |
| CA3089569C (en) | 2007-06-04 | 2023-12-05 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| EP2321341B1 (en) | 2008-07-16 | 2017-02-22 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CN108676076A (zh) | 2011-03-01 | 2018-10-19 | 辛纳吉制药公司 | 制备鸟苷酸环化酶c激动剂的方法 |
| US20150119399A1 (en) | 2012-01-10 | 2015-04-30 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
| JP6499591B2 (ja) | 2013-02-25 | 2019-04-10 | シナジー ファーマシューティカルズ インコーポレイテッド | 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| JP2016514670A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト |
| RS65632B1 (sr) | 2013-06-05 | 2024-07-31 | Bausch Health Ireland Ltd | Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe |
| WO2015021358A2 (en) | 2013-08-09 | 2015-02-12 | Dominique Charmot | Compounds and methods for inhibiting phosphate transport |
| US9884806B2 (en) | 2013-08-30 | 2018-02-06 | Icahn School Of Medicine At Mount Sinai | Cyclic vinylogous amides as bromodomain inhibitors |
| JP2022533251A (ja) | 2019-05-21 | 2022-07-21 | アルデリックス， インコーポレイテッド | 患者において血清リン酸塩を低下させるための組み合わせ |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4019575A (en) * | 1975-12-22 | 1977-04-26 | Chevron Research Company | System for recovering viscous petroleum from thick tar sand |
| JPS5746966A (en) * | 1980-09-03 | 1982-03-17 | Mitsui Toatsu Chem Inc | Pyridazinone derivative and its production |
| US4665174A (en) * | 1981-05-12 | 1987-05-12 | Sumitomo Chemical Company, Limited | Production of cyclopentenone derivatives |
| JPS58113180A (ja) * | 1981-12-28 | 1983-07-05 | Mitsui Toatsu Chem Inc | ピリダジノン誘導体 |
| DE3302442A1 (de) * | 1983-01-26 | 1984-07-26 | Basf Ag, 6700 Ludwigshafen | Neue pyridazinone, verfahren zu ihrer herstellung, diese verbindungen enthaltende therapeutische mittel und deren verwendung |
| US4602019A (en) * | 1983-04-22 | 1986-07-22 | Warner-Lambert Company | Indeno[1,2-c]pyridazin-3-one derivatives useful as cardiotonic and antihypertensive agents |
| US4666902A (en) * | 1983-06-20 | 1987-05-19 | Cassella Aktiengesellschaft | Tetrahydropyridazinone derivatives, processes for their preparation and their use |
| GB2164643B (en) * | 1984-07-27 | 1988-11-02 | Boehringer Biochemia Srl | Tricyclic dihydropyridazinones and pharmaceutical compositions containing them |
| JPH06763B2 (ja) * | 1984-08-28 | 1994-01-05 | 吉富製薬株式会社 | ベンゾ〔ｈ〕シンノリン誘導体 |
| US4816454A (en) * | 1984-09-21 | 1989-03-28 | Cassella Aktiengesellschaft | 4,5-dihydro-3(2H)-pyridazinones and their pharmacological use |
| US4681621A (en) * | 1984-12-20 | 1987-07-21 | Stauffer Chemical Company | Herbicidal 2-(2-substituted benzoyl)-1,3-cyclopentanediones |
| DE3505609A1 (de) * | 1985-02-19 | 1986-08-21 | Merck Patent Gmbh, 6100 Darmstadt | Benzimidazolyl-pyridazinone |
| GB2177689B (en) * | 1985-07-09 | 1989-07-19 | Boehringer Biochemia Srl | Tricyclic dihydropyridazinones and pharmaceutical compositions containing them |
| JPH0633277B2 (ja) * | 1986-01-10 | 1994-05-02 | 吉富製薬株式会社 | ベンゾチオピラノ〔４，３−ｃ〕ピリダジン化合物 |
| US4775411A (en) * | 1986-06-09 | 1988-10-04 | Stauffer Chemica Company | Certain substituted 3-amino-2-benzoylcyclohex-2-enones |
| ES2038708T3 (es) * | 1987-03-02 | 1996-07-16 | Yoshitomi Pharmaceutical | Metodo para producir compuestos de benzotiepino(5,4-c)piridazina. |
| DE3804490A1 (de) * | 1988-02-12 | 1989-08-24 | Heumann Pharma Gmbh & Co | Substituierte 6-phenyldihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| JPH0216991A (ja) * | 1988-07-04 | 1990-01-19 | Mitsui Toatsu Chem Inc | Ｌ−トリプトファンの製法 |
-
1989
- 1989-01-31 JP JP1019514A patent/JP2717687B2/ja not_active Expired - Lifetime
- 1989-02-09 CA CA000590590A patent/CA1320957C/en not_active Expired - Fee Related
- 1989-02-09 KR KR1019890701882A patent/KR910005233B1/ko not_active IP Right Cessation
- 1989-02-09 EP EP89902288A patent/EP0357788B1/en not_active Expired - Lifetime
- 1989-02-09 US US07/427,123 patent/US5110925A/en not_active Expired - Fee Related
- 1989-02-09 DE DE89902288T patent/DE68910447T2/de not_active Expired - Fee Related
- 1989-02-09 WO PCT/JP1989/000127 patent/WO1989007594A1/en active IP Right Grant
- 1989-02-10 ES ES8900493A patent/ES2012646A6/es not_active Expired - Fee Related
- 1989-10-10 DK DK502389A patent/DK170096B1/da not_active IP Right Cessation
- 1989-10-12 NO NO894088A patent/NO176275C/no unknown
- 1989-10-12 FI FI894844A patent/FI95570C/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO894088L (no) | 1989-10-12 |
| NO894088D0 (no) | 1989-10-12 |
| US5110925A (en) | 1992-05-05 |
| WO1989007594A1 (en) | 1989-08-24 |
| EP0357788B1 (en) | 1993-11-03 |
| CA1320957C (en) | 1993-08-03 |
| EP0357788A1 (en) | 1990-03-14 |
| DK502389A (da) | 1989-11-20 |
| DE68910447T2 (de) | 1994-03-17 |
| FI95570C (fi) | 1996-02-26 |
| FI894844A0 (fi) | 1989-10-12 |
| JP2717687B2 (ja) | 1998-02-18 |
| KR900700462A (ko) | 1990-08-13 |
| FI95570B (fi) | 1995-11-15 |
| DK502389D0 (da) | 1989-10-10 |
| JPH0256468A (ja) | 1990-02-26 |
| DK170096B1 (da) | 1995-05-22 |
| KR910005233B1 (ko) | 1991-07-24 |
| DE68910447D1 (de) | 1993-12-09 |
| ES2012646A6 (es) | 1990-04-01 |
| NO176275B (no) | 1994-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI96861C (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi | |
| NO179584C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler | |
| NO173545C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater | |
| NO176275C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater | |
| NO174101C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater | |
| NO159016C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater. | |
| NO178619C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler | |
| NO179448C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser | |
| NO174467C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater | |
| NO178068C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive tiazolidindionderivater | |
| FI96601C (fi) | Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi | |
| NO165841C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater. | |
| NO173334C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner | |
| NO172849C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazol- og oksazol-derivater | |
| FI93444B (fi) | Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi | |
| NO174391C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater | |
| NO174422C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater | |
| NO171065C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater | |
| NO174203C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive | |
| NO169652C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive guaninderivater | |
| NO173606C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno- triazolo-diazepin-derivater | |
| NO174463C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrrolidinderivater | |
| NO304428B1 (no) | AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler | |
| NO167668C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive epipodofyllotoksinglukosid-4'-acylderivater. | |
| NO177673C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive N7-substituerte mitomycinderivater |